Company / Operating Margin
Serina Therapeutics, Inc. Operating Margin History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-18478.5%
FY2025
5-year range
-20514.7% / -99.2%
FY2021-FY2025
Trend
-18520.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Margin changed -18520% YoY in FY2025, a notable deviation from the 6-year average annual change of -3224%.
Based on SEC 10-K filings.
-18478.5% in FY2025 with a 5-year CAGR of -17751.7%.
Declined from -99.2% to -18478.5% over the past 2 years.
Operating Margin over time
Growth rates
- 3-Year Change
- +2036.2pp
- 5-Year Change
- -17751.7pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, operating margin decreased 18520.0% year-over-year.
- Peak operating margin was recorded in FY2024.
- Lowest operating margin in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -18.20 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -18478.5% | -18520.0% |
| FY2024 | -99.2% | +0.0% |
| FY2023 | -99.2% | +99.5% |
| FY2022 | -20514.7% | -272.4% |
| FY2021 | -5509.0% | -658.0% |
| FY2020 | -726.8% | +9.8% |
| FY2018 | -805.5% | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026